News Releases
The latest company news, press releases, and resources about Servier and everything our company has to offer.
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
11.10.2025Servier's Clinical and Real-World Data at 2025 SNO Congress Showcase Leadership in IDH-Mutant Glioma-
11.06.2025Servier's New and Updated Data at 2025 ASH Annual Meeting Highlight Commitment to Hematology Research
-
11.03.2025Servier Announces Positive Findings from Longer-Term Analysis of the Phase 3 INDIGO Trial Showing Continued Durable Treatment Effect of VORANIGO® (vorasidenib) Published in The Lancet Oncology
-
10.31.2025Servier's VORANIGO® (vorasidenib) Receives Prestigious 2025 Prix Galien USA Award
-
09.22.2025European Commission Approves Servier's VORANIGO® (vorasidenib) as the First Targeted Therapy for Grade 2 IDH-Mutant Glioma in the EU
Media Contacts
Sara Noonan
sara.noonan@servier.com